Matches in Wikidata for { <http://www.wikidata.org/entity/Q92023816> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q92023816 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q92023816 description "scientific article published on 20 March 2020" @default.
- Q92023816 description "wetenschappelijk artikel" @default.
- Q92023816 description "наукова стаття, опублікована 20 березня 2020" @default.
- Q92023816 name "Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities" @default.
- Q92023816 name "Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities" @default.
- Q92023816 type Item @default.
- Q92023816 label "Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities" @default.
- Q92023816 label "Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities" @default.
- Q92023816 prefLabel "Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities" @default.
- Q92023816 prefLabel "Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities" @default.
- Q92023816 P1433 Q92023816-D93746C2-2ECE-4441-B1A5-DA0063D880CB @default.
- Q92023816 P1476 Q92023816-1EEA24D4-E111-4B67-9C33-BC5FE5BBCCA7 @default.
- Q92023816 P2093 Q92023816-00926D86-B09C-41E7-960A-7FA4CA97A81F @default.
- Q92023816 P2093 Q92023816-096A8333-6E13-4081-B8CD-20171E88D4D8 @default.
- Q92023816 P2093 Q92023816-26CAEB82-63D0-42E3-AE70-DADD1834A7A0 @default.
- Q92023816 P2093 Q92023816-46C61B07-C68B-409A-8521-087F16228E09 @default.
- Q92023816 P2093 Q92023816-5208B0A1-5EBA-4ACC-A741-FC954286D465 @default.
- Q92023816 P2093 Q92023816-57D51FA6-C294-4AA5-9907-8955DC34CC53 @default.
- Q92023816 P2093 Q92023816-5D749742-2443-4B3A-94BE-BBA0088FE4B7 @default.
- Q92023816 P2093 Q92023816-644BFF29-B810-4BF0-BD42-17C5F238F99E @default.
- Q92023816 P2093 Q92023816-698E25BD-07FB-46DB-B02C-595BD1608F88 @default.
- Q92023816 P2093 Q92023816-7A1D0357-199B-46D4-A549-781A873A4C9A @default.
- Q92023816 P2093 Q92023816-C1C346D6-CDAD-4768-838E-957989E232D0 @default.
- Q92023816 P2093 Q92023816-CD1FDB14-2CDC-40FF-9ECD-1B7E11C54937 @default.
- Q92023816 P2093 Q92023816-CF097AC6-9D15-4156-A25D-A5DFE6DA6BA7 @default.
- Q92023816 P2093 Q92023816-EADEC970-B51B-48F4-ADCD-C07BB5E4E5C9 @default.
- Q92023816 P2093 Q92023816-FEA067FB-EF23-44C0-834F-841D23710D7D @default.
- Q92023816 P31 Q92023816-EC4FA29D-C632-4F91-B12D-81F778B85514 @default.
- Q92023816 P356 Q92023816-44BAA297-89A0-4988-833F-30C7F3CA500B @default.
- Q92023816 P50 Q92023816-2EA628CD-E6B8-4CCB-87EC-04D54EEC0599 @default.
- Q92023816 P577 Q92023816-CE001497-1D0F-4A19-BD24-1FA6AC5A9958 @default.
- Q92023816 P698 Q92023816-1073691D-7504-430B-B249-40FFD6C1635D @default.
- Q92023816 P356 J.CLML.2020.03.005 @default.
- Q92023816 P698 32303488 @default.
- Q92023816 P1433 Q5133774 @default.
- Q92023816 P1476 "Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities" @default.
- Q92023816 P2093 "Alan F List" @default.
- Q92023816 P2093 "Amy DeZern" @default.
- Q92023816 P2093 "David A Sallman" @default.
- Q92023816 P2093 "David P Steensma" @default.
- Q92023816 P2093 "Elias Jabbour" @default.
- Q92023816 P2093 "Eric Padron" @default.
- Q92023816 P2093 "Gail Roboz" @default.
- Q92023816 P2093 "Hagop Kantarjian" @default.
- Q92023816 P2093 "Jaroslaw P Maciejewski" @default.
- Q92023816 P2093 "Jeffrey E Lancet" @default.
- Q92023816 P2093 "John Barnard" @default.
- Q92023816 P2093 "Mikkael A Sekeres" @default.
- Q92023816 P2093 "Najla H Al Ali" @default.
- Q92023816 P2093 "Rami S Komrokji" @default.
- Q92023816 P2093 "Sherry Pierce" @default.
- Q92023816 P31 Q13442814 @default.
- Q92023816 P356 "10.1016/J.CLML.2020.03.005" @default.
- Q92023816 P50 Q66385413 @default.
- Q92023816 P577 "2020-03-20T00:00:00Z" @default.
- Q92023816 P698 "32303488" @default.